About this trial
Age is a major risk factor for the development of cognitive disorders and neurodegenerative pathologies. Cognitive disorders during the phases of bipolar disease are known to exist, and alterations increase significantly after the age of 65. Drug treatments seem to have only a limited effect. A cognitive stimulation program has proven his benefit to patients over 65 with neurodegenerative diseases (Israel, 2004). We propose to evaluate this cognitive stimulation program that we have adapted to bipolar disease.
Eligibility criteria
Qualifiers
age > 65 years old
Diagnosis of bipolar illness for more than 10 years
Euthymic phase
Understands and speaks French
Disqualifiers
Illiteracy
Patient participating in other therapeutic workshops (e. g. psycho-geriatric day hospital care, etc.)
Persons deprived of their liberty by a judicial or administrative decision
Persons of full age who are subject to a legal protection measure
Trial design
Treatments tested in this trial
- cognitive stimulation